Physician profile
Namita Murthy
NPI 1407148950
$322.47
in general payments reported to CMS, 2019-2025
9 companies · $23.12 in 2025
The $23.12 reported for 2025 was less than what a typical Plastic Surgery Within The Head & Neck provider received nationally (typical 2025 total: $238).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $149 · 2020: $47.60 · 2024: $103 · 2025: $23.12.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $126.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $125.74 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Revance Therapeutics, INC. | $110.33 | 2024-2025 | Daxxify |
| Stryker Corporation | $48.63 | 2019-2020 | |
| Alk-Abello, INC | $48.07 | 2019 | |
| Acclarent, INC | $35.60 | 2019 | |
| Intersect Ent, INC. | $19.37 | 2019 | |
| Genzyme Corporation | $16.45 | 2020 | |
| Medtronic USA, INC. | $16.35 | 2020 | |
| Galderma Laboratories, L.P. | $15.41 | 2024 | |
| Smith+Nephew, INC. | $12.26 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Namita Murthy listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.